Drug archive
Immune Globulin Intravenous (Human) (Systemic)Additional Information
Archived drug information. This USP DI monograph is kept for reference and dates from the mid-2000s. Doses, warnings, interactions and brand names may have changed, and some products are no longer sold. Always follow your prescriber, your pharmacist and the current label, for example on DailyMed.
Additional Information
Once a medicine has been approved for marketing for a certain use, experience may show that it is also useful for other medical problems. Although these uses are not included in product labeling, IGIV is used in certain patients with the following medical conditions:
- Chronic parvovirus B19 infection (treatment)
- Chronic inflammatory demyelinating polyneuropathies (treatment)
- Dermatomyositis (treatment)
- Guillain-Barré syndrome (treatment)
- Hyperimmunoglobulinemia E syndrome (treatment)
- Infections in low-birth-weight preterm high-risk neonates (prophylaxis and treatment adjunct)
- Lambert-Eaton myasthenic syndrome (treatment)
- Multifocal motor neuropathy (treatment)
- Relapsing-remitting multiple sclerosis (treatment)
Other than the above information, there is no additional information relating to proper use, precautions, or side effects for its use.